Please assess the completion status of the following clinical trial:

Trial Title: Use of Rectal Dialysis Technique to Measure Rectal 5-ASA Levels in Healthy Volunteers Receiving Asacol

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Eligible subjects would be healthy males and females~* 18-45 years of age (inclusive)~* Within 20% of normal body weight at screening~* Who are able to give written informed consent.~Exclusion Criteria:~* History of any chronic illness~* Evidence of significant organic or psychiatric disease on a brief health questionnaire~* A history or presence of any condition causing malabsorption or an effect on gastrointestinal motility~* A history of any gastrointestinal surgery~* A history of acute or chronic renal insufficiency~* Pre existing liver disease~* A history of severe allergic reaction to salicylates, aminosalicylates or any of the ingredients of Asacol® tablets or a history of multiple food/drug allergies or if they are pregnant or lactating.~* Subjects will be required to refrain from any prescription or nonprescription drug or herbal products except their birth control medications for gastrointestinal disorders for 7 days prior to dosing and during the study, till its completion at the end of the fifth visit.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- 1200 mg Asacol once daily for 1 week (Type: ACTIVE_COMPARATOR): Rectal dialysis will be done after 1 week on 1200 mg asacol
- 2400 mg Asacol once daily for 1 week (Type: ACTIVE_COMPARATOR): Rectal dialysis will be done after 1 week on 2400 mg asacol

Based on this trial design, predict the completion outcome and termination type (if applicable).